Today’s podcast features a discussion on health value assessments, drug costs, and the potential implications for men diagnosed with prostate cancer. Interviewed on this topic are Robert Popovian, Doctor in Pharmacy and Vice President, US Government Relations at Pfizer Inc, and William Smith, PhD, Visiting Fellow on Life Sciences at the Pioneer Institute of Boston.